|
1
|
Mariette X and Criswell LA: Primary
Sjögren's syndrome. N Engl J Med. 378:931–939. 2018.
|
|
2
|
Baimpa E, Dahabreh IJ, Voulgarelis M and
Moutsopoulos HM: Hematologic manifestations and predictors of
lymphoma development in primary Sjögren syndrome: Clinical and
pathophysiologic aspects. Medicine (Baltimore). 88:284–293.
2009.
|
|
3
|
Voulgarelis M, Dafni UG, Isenberg DA and
Moutsopoulos HM: Malignant lymphoma in primary Sjögren's syndrome:
A multicenter, retrospective, clinical study by the European
concerted action on Sjögren's syndrome. Arthritis Rheum.
42:1765–1772. 1999.
|
|
4
|
Nordmark G, Alm GV and Rönnblom L:
Mechanisms of disease: Primary Sjögren's syndrome and the type I
interferon system. Nat Clin Pract Rheumatol. 2:262–269. 2006.
|
|
5
|
Llorente L, Richaud-Patin Y, Fior R,
Alcocer-Varela J, Wijdenes J, Fourrier BM, Galanaud P and Emilie D:
In vivo production of interleukin-10 by non-T cells in rheumatoid
arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A
potential mechanism of B lymphocyte hyperactivity and autoimmunity.
Arthritis Rheum. 37:1647–1655. 1994.
|
|
6
|
Halse A, Tengnér P, Wahren-Herlenius M,
Haga H and Jonsson R: Increased frequency of cells secreting
interleukin-6 and interleukin-10 in peripheral blood of patients
with primary Sjögren's syndrome. Scand J Immunol. 49:533–538.
1999.
|
|
7
|
Fox RI, Pearson G and Vaughan JH:
Detection of Epstein-Barr virus-associated antigens and DNA in
salivary gland biopsies from patients with Sjogren's syndrome. J
Immunol. 137:3162–3168. 1986.
|
|
8
|
Igoe A and Scofield RH: Autoimmunity and
infection in Sjögren's syndrome. Curr Opin Rheumatol. 25:480–487.
2013.
|
|
9
|
Sipsas NV, Gamaletsou MN and Moutsopoulos
HM: Is Sjögren's syndrome a retroviral disease? Arthritis Res Ther.
13:2122011.
|
|
10
|
Bowman SJ: Primary Sjögren's syndrome.
Lupus. 27(Suppl 1): S32–S35. 2018.
|
|
11
|
Bulun SE, Yilmaz BD, Sison C, Miyazaki K,
Bernardi L, Liu S, Kohlmeier A, Yin P, Milad M and Wei J:
Endometriosis. Endocr Rev. 40:1048–1079. 2019.
|
|
12
|
Simpson JL and Bischoff FZ: Heritability
and molecular genetic studies of endometriosis. Ann N Y Acad Sci.
955:239–251. 2002.
|
|
13
|
Stefansson H, Geirsson RT,
Steinthorsdottir V, Jonsson H, Manolescu A, Kong A, Ingadottir G,
Gulcher J and Stefansson K: Genetic factors contribute to the risk
of developing endometriosis. Hum Reprod. 17:555–559. 2002.
|
|
14
|
Montgomery GW, Nyholt DR, Zhao ZZ, Treloar
SA, Painter JN, Missmer SA, Kennedy SH and Zondervan KT: The search
for genes contributing to endometriosis risk. Hum Reprod Update.
14:447–457. 2008.
|
|
15
|
Symons LK, Miller JE, Kay VR, Marks RM,
Liblik K, Koti M and Tayade C: The immunopathophysiology of
endometriosis. Trends Mol Med. 24:748–762. 2018.
|
|
16
|
Berkley KJ, Rapkin AJ and Papka RE: The
pains of endometriosis. Science. 308:1587–1589. 2005.
|
|
17
|
Parente Barbosa C, Bentes De Souza AM,
Bianco B and Christofolini DM: The effect of hormones on
endometriosis development. Minerva Ginecol. 63:375–386. 2011.
|
|
18
|
Simpson JL, Elias S, Malinak LR and
Buttram VC Jr: Heritable aspects of endometriosis. I. Genetic
studies. Am J Obstet Gynecol. 137:327–331. 1980.
|
|
19
|
De Ziegler D, Borghese B and Chapron C:
Endometriosis and infertility: Pathophysiology and management.
Lancet. 376:730–738. 2010.
|
|
20
|
Maddern J, Grundy L, Castro J and Brierley
SM: Pain in endometriosis. Front cell neurosci. 14:5908232020.
|
|
21
|
Sampson JA: Peritoneal endometriosis due
to menstrual dissemination of endometrial tissue into the
peritoneal cavity. Am J Obstet Gynecol. 14:422–469. 1927.
|
|
22
|
Vercellini P, Frontino G, Pietropaolo G,
Gattei U, Daguati R and Crosignani PG: Deep endometriosis:
Definition, pathogenesis, and clinical management. J Am Assoc
Gynecol Laparosc. 11:153–161. 2004.
|
|
23
|
Yovich JL, Rowlands PK, Lingham S,
Sillender M and Srinivasan S: Pathogenesis of endometriosis: Look
no further than John Sampson. Reprod Biomed Online. 40:7–11.
2020.
|
|
24
|
Parasar P, Ozcan P and Terry KL:
Endometriosis: Epidemiology, diagnosis and clinical management.
Curr Obstet Gynecol Rep. 6:34–41. 2017.
|
|
25
|
Kvaskoff M, Mu F, Terry KL, Harris HR,
Poole EM, Farland L and Missmer SA: Endometriosis: A high-risk
population for major chronic diseases? Hum Reprod Update.
21:500–516. 2015.
|
|
26
|
Rafi U, Ahmad S, Bokhari SS, Iqbal MA, Zia
A, Khan MA and Roohi N: Association of inflammatory
markers/cytokines with cardiovascular risk manifestation in
patients with endometriosis. Mediators Inflamm.
2021:34255602021.
|
|
27
|
Vazgiourakis VM, Zervou MI, Papageorgiou
L, Chaniotis D, Spandidos DA, Vlachakis D, Eliopoulos E and
Goulielmos GN: Association of endometriosis with cardiovascular
disease: Genetic aspects (review). Int J Mol Med. 51:292023.
|
|
28
|
Surrey ES, Soliman AM, Johnson SJ, Davis
M, Castelli-Haley J and Snabes MC: Risk of developing comorbidities
among women with endometriosis: A retrospective matched cohort
study. J Womens Health (Larchmt). 27:1114–1123. 2018.
|
|
29
|
Shigesi N, Kvaskoff M, Kirtley S, Feng Q,
Fang H, Knight JC, Missmer SA, Rahmioglu N, Zondervan KT and Becker
CM: The association between endometriosis and autoimmune diseases:
A systematic review and meta-analysis. Hum Reprod Update.
25:486–503. 2019.
|
|
30
|
Zervou MI, Vlachakis D, Papageorgiou L,
Eliopoulos E and Goulielmos GN: Increased risk of rheumatoid
arthritis in patients with endometriosis: Genetic aspects.
Rheumatology (Oxford). 61:4252–4262. 2022.
|
|
31
|
Yin Z, Low HY, Chen BS, Huang KS, Zhang Y,
Wang YH, Ye Z and Wei JCC: Risk of ankylosing spondylitis in
patients with endometriosis: A population-based retrospective
cohort study. Front Immunol. 13:8779422022.
|
|
32
|
Zervou MI, Papageorgiou L, Vlachakis D,
Spandidos DA, Eliopoulos E and Goulielmos GN: Genetic factors
involved in the co-occurrence of endometriosis with ankylosing
spondylitis (review). Mol Med Rep. 27:962023.
|
|
33
|
Zizolfi B, Foreste V, Bonavita S, Rubino
V, Ruggiero G, Brescia Morra V, Lanzillo R, Carotenuto A, Boscia F,
Taglialatela M and Guida M: Epidemiological and immune profile
analysis of Italian subjects with endometriosis and multiple
sclerosis. J Clin Med. 12:20432023.
|
|
34
|
Nielsen NM, Jørgensen KT, Pedersen BV,
Rostgaard K and Frisch M: The co-occurrence of endometriosis with
multiple sclerosis, systemic lupus erythematosus and Sjogren
syndrome. Hum Reprod. 26:1555–1559. 2011.
|
|
35
|
Ma L, Li Z, Li W, Ai J and Chen X:
MicroRNA-142-3p suppresses endometriosis by regulating
KLF9-mediated autophagy in vitro and in vivo. RNA Biol.
16:1733–1748. 2019.
|
|
36
|
Chao YH, Liu CH, Pan YA, Yen FS, Chiou JY
and Wei JCC: Association between endometriosis and subsequent risk
of Sjögren's syndrome: A nationwide population-based cohort study.
Front Immunol. 13:8459442022.
|
|
37
|
Treloar SA, O'Connor DT, O'Connor VM and
Martin NG: Genetic influences on endometriosis in an Australian
twin sample. simplesueT@qimr.edu.au. Fertil
Steril. 71:701–710. 1999.
|
|
38
|
Saha R, Pettersson HJ, Svedberg P,
Olovsson M, Bergqvist A, Marions L, Tornvall P and Kuja-Halkola R:
Heritability of endometriosis. Fertil Steril. 104:947–952.
2015.
|
|
39
|
Treloar SA, Wicks J, Nyholt DR, Montgomery
GW, Bahlo M, Smith V, Dawson G, Mackay IJ, Weeks DE, Bennett ST, et
al: Genomewide linkage study in 1,176 affected sister pair families
identifies a significant susceptibility locus for endometriosis on
chromosome 10q26. Am J Hum Genet. 77:365–376. 2005.
|
|
40
|
Falconer H, D'Hooghe T and Fried G:
Endometriosis and genetic polymorphisms. Obstet Gynecol Surv.
62:616–628. 2007.
|
|
41
|
Nyholt DR, Low SK, Anderson CA, Painter
JN, Uno S, Morris AP, MacGregor S, Gordon SD, Henders AK, Martin
NG, et al: Genome-wide association meta-analysis identifies new
endometriosis risk loci. Nat Genet. 44:1355–1359. 2012.
|
|
42
|
Falconer H, Sundqvist J, Xu H, Vodolazkaia
A, Fassbender A, Kyama C, Bokor A and D'Hooghe TM: Analysis of
common variations in tumor-suppressor genes on chr1p36 among
Caucasian women with endometriosis. Gynecol Oncol. 127:398–402.
2012.
|
|
43
|
Kobayashi H, Imanaka S, Nakamura H and
Tsuji A: Understanding the role of epigenomic, genomic and genetic
alterations in the development of endometriosis (Review). Mol Med
Rep. 9:1483–1505. 2014.
|
|
44
|
Rahmioglu N, Nyholt DR, Morris AP, Missmer
SA, Montgomery GW and Zondervan KT: Genetic variants underlying
risk of endometriosis: Insights from meta-analysis of eight
genome-wide association and replication datasets. Hum Reprod
Update. 20:702–716. 2014.
|
|
45
|
Sapkota Y, Fassbender A, Bowdler L, Fung
JN, Peterse D, O D, Montgomery GW, Nyholt DR and D'Hooghe TM:
Independent replication and meta-analysis for endometriosis risk
loci. Twin Res Hum Genet. 18:518–525. 2015.
|
|
46
|
Sapkota Y, Steinthorsdottir V, Morris AP,
Fassbender A, Rahmioglu N, De Vivo I, Buring JE, Zhang F, Edwards
TL, Jones S, et al: Meta-analysis identifies five novel loci
associated with endometriosis highlighting key genes involved in
hormone metabolism. Nat Commun. 8:155392017.
|
|
47
|
Zondervan KT, Becker CM, Koga K, Missmer
SA, Taylor RN and Viganò P: Endometriosis. Nat Rev Dis Primers.
4:92018.
|
|
48
|
Matalliotakis M, Zervou MI, Matalliotaki
C, Rahmioglu N, Koumantakis G, Kalogiannidis I, Prapas I, Zondervan
K, Spandidos DA, Matalliotakis I and Goulielmos GN: The role of
gene polymorphisms in endometriosis. Mol Med Rep. 16:5881–5886.
2017.
|
|
49
|
Matalliotakis M, Zervou MI, Eliopoulos E,
Matalliotaki C, Rahmioglu N, Kalogiannidis I, Zondervan K,
Spandidos DA, Matalliotakis I and Goulielmos GN: The role of IL-16
gene polymorphisms in endometriosis. Int J Mol Med. 41:1469–1476.
2018.
|
|
50
|
Uimari O, Rahmioglu N, Nyholt DR, Vincent
K, Missmer SA, Becker C, Morris AP, Montgomery GW and Zondervan KT:
Genome-wide genetic analyses highlight mitogen-activated protein
kinase (MAPK) signaling in the pathogenesis of endometriosis. Hum
Reprod. 32:780–793. 2017.
|
|
51
|
Albertsen HM, Matalliotaki C,
Matalliotakis M, Zervou MI, Matalliotakis I, Spandidos DA, Chettier
R, Ward K and Goulielmos GN: Whole exome sequencing identifies
hemizygous deletions in the UGT2B28 and USP17L2 genes in a
three-generation family with endometriosis. Mol Med Rep.
19:1716–1720. 2019.
|
|
52
|
Vassilopoulou L, Matalliotakis M, Zervou
MI, Matalliotaki C, Krithinakis K, Matalliotakis I, Spandidos DA
and Goulielmos GN: Defining the genetic profile of endometriosis.
Exp Ther Med. 17:3267–3281. 2019.
|
|
53
|
Rahmioglu N, Mortlock S, Ghiasi M, Møller
PL, Stefansdottir L, Galarneau G, Turman C, Danning R, Law MH,
Sapkota Y, et al: The genetic basis of endometriosis and
comorbidity with other pain and inflammatory conditions. Nat Genet.
55:423–436. 2023.
|
|
54
|
Goulielmos GN, Matalliotakis M,
Matalliotaki C, Eliopoulos E, Matalliotakis I and Zervou MI:
Endometriosis research in the-omics era. Gene. 741:1445452020.
|
|
55
|
Zelenko Z, Aghajanova L, Irwin JC and
Giudice LC: Nuclear receptor, coregulator signaling, and chromatin
remodeling pathways suggest involvement of the epigenome in the
steroid hormone response of endometrium and abnormalities in
endometriosis. Reprod Sci. 19:152–162. 2012.
|
|
56
|
Tan M, Luo H, Lee S, Jin F, Yang JS,
Montellier E, Buchou T, Cheng Z, Rousseaux S, Rajagopal N, et al:
Identification of 67 histone marks and histone lysine crotonylation
as a new type of histone modification. Cell. 146:1016–1028.
2011.
|
|
57
|
Koukoura O, Sifakis S and Spandidos DA:
DNA methylation in endometriosis (Review). Mol Med Rep.
13:939–2948. 2016.
|
|
58
|
Hsiao KY, Wu MH and Tsai SJ: Epigenetic
regulation of the pathological process in endometriosis. Reprod Med
Biol. 16:314–319. 2017.
|
|
59
|
Kim YJ, Yeon Y, Lee WJ, Shin YU, Cho H,
Sung YK, Kim DR, Lim HW and Kang MH: Comparison of MicroRNA
expression in tears of normal subjects and Sjögren syndrome
patients. Investig Ophthalmol Vis Sci. 60:4889–4895. 2019.
|
|
60
|
Horvath S: DNA methylation age of human
tissues and cell types. Genome Biol. 14:R1152013.
|
|
61
|
Teos LY and Alevizos I: Genetics of
Sjögren's syndrome. Clin Immunol. 182:41–47. 2017.
|
|
62
|
Moriuchi J, Ichikawa Y, Takaya M, Shimizu
H, Uchiyama M, Sato K, Tsuji K and Arimori S: Association between
HLA and Sjögren's syndrome in Japanese patients. Arthritis Rheum.
29:1518–1521. 1986.
|
|
63
|
Wang J, Jiang M and Qiu C: Study on the
relationship between primary Sjögren syndrome and HLA-DRbeta gene.
Zhonghua Nei Ke Za Zhi. 36:398–401. 1997.In Chinese.
|
|
64
|
Hernández-Molina G, Vargas-Alarcón G,
Rodríguez-Pérez JM, Martínez-Rodríguez N, Lima G and
Sánchez-Guerrero J: High-resolution HLA analysis of primary and
secondary Sjögren's syndrome: A common immunogenetic background in
Mexican patients. Rheumatol Int. 35:643–649. 2015.
|
|
65
|
Roitberg-Tambur A, Friedmann A, Safirman
C, Markitziu A, Ben-Chetrit E, Rubinow A, Moutsopoulos HM,
Stavropoulos E, Skopouli FN, Margalit H, et al: Molecular analysis
of HLA class II genes in primary Sjögren's syndrome. A study of
Israeli Jewish and Greek non-Jewish patients. Hum Immunol.
36:235–242. 1993.
|
|
66
|
Manoussakis MN, Georgopoulou C, Zintzaras
E, Spyropoulou M, Stavropoulou A, Skopouli FN and Moutsopoulos HM:
Sjögren's syndrome associated with systemic lupus erythematosus:
Clinical and laboratory profiles and comparison with primary
Sjögren's syndrome. Arthritis Rheum. 50:882–891. 2004.
|
|
67
|
García Portales R, Belmonte Lope MA, Camps
García MT, Ocón Sánchez P, Alonso Ortiz A, Guil García M and de
Ramón Garrido E: Immunogenetics of the Sjogren's syndrome in
southern Spain. An Med Interna. 11:56–61. 1994.In Spanish.
|
|
68
|
Imgenberg-Kreuz J, Sandling JK and
Nordmark G: Epigenetic alterations in primary Sjögren's syndrome-an
overview. Clin Immunol. 196:12–20. 2018.
|
|
69
|
Lessard CJ, Li H, Adrianto I, Ice JA,
Rasmussen A, Grundahl KM, Kelly JA, Dozmorov MG, Miceli-Richard C,
Bowman S, et al: Variants at multiple loci implicated in both
innate and adaptive immune responses are associated with Sjögren's
syndrome. Nat Genet. 45:1284–1292. 2013.
|
|
70
|
Li Y, Zhang K, Chen H, Sun F, Xu J, Wu Z,
Li P, Zhang L, Du Y, Luan H, et al: A genome-wide association study
in Han Chinese identifies a susceptibility locus for primary
Sjögren's syndrome at 7q11.23. Nat Genet. 45:1361–1365. 2013.
|
|
71
|
Taylor KE, Wong Q, Levine DM, McHugh C,
Laurie C, Doheny K, Lam MY, Baer AN, Challacombe S, Lanfranchi H,
et al: Genome-wide association analysis reveals genetic
heterogeneity of Sjögren's syndrome according to ancestry.
Arthritis Rheumatol. 69:1294–1305. 2017.
|
|
72
|
Bolstad AI and Jonsson R: Genetic aspects
of Sjögren's syndrome. Arthritis Res. 4:353–359. 2002.
|
|
73
|
Li H, Reksten TR, Ice JA, Kelly JA,
Adrianto I, Rasmussen A, Wang S, He B, Grundahl KM, Glenn SB, et
al: Identification of a Sjögren's syndrome susceptibility locus at
OAS1 that influences isoform switching, protein expression, and
responsiveness to type I interferons. PLoS Genet.
13:e10068202017.
|
|
74
|
Eisenberg VH, Zolti M and Soriano D: Is
there an association between autoimmunity and endometriosis?
Autoimmun Rev. 11:806–814. 2012.
|
|
75
|
Khatri B, Tessneer KL, Rasmussen A,
Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi
LA, Baecklund E, et al: Genome-wide association study identifies
Sjögren's risk loci with functional implications in immune and
glandular cells. Nat Commun. 13:42872022.
|
|
76
|
Gottenberg JE, Cagnard N, Lucchesi C,
Letourneur F, Mistou S, Lazure T, Jacques S, Ba N, Ittah M,
Lepajolec C, et al: Activation of IFN pathways and plasmacytoid
dendritic cell recruitment in target organs of primary Sjögren's
syndrome. Proc Natl Acad Sci USA. 103:2770–2775. 2006.
|
|
77
|
Wildenberg ME, van Helden-Meeuwsen CG, van
de Merwe JP, Drexhage HA and Versnel MA: Systemic increase in type
I interferon activity in Sjögren's syndrome: A putative role for
plasmacytoid dendritic cells. Eur J Immunol. 38:2024–2033.
2008.
|
|
78
|
Matarese G, De Placido G, Nikas Y and
Alviggi C: Pathogenesis of endometriosis: Natural immunity
dysfunction or autoimmune disease? Trends Mol Med. 9:223–228.
2003.
|
|
79
|
Wilson TJ, Hertzog PJ, Angus D, Munnery L,
Wood EC and Kola I: Decreased natural killer cell activity in
endometriosis patients: Relationship to disease pathogenesis.
Fertil Steril. 62:1086–1088. 1994.
|
|
80
|
Burns KA, Thomas SY, Hamilton KJ, Young
SL, Cook DN and Korach KS: Early endometriosis in females is
directed by immune-mediated estrogen receptor a and IL-6
cross-talk. Endocrinology. 159:103–118. 2018.
|
|
81
|
Graziottin A, Skaper SD and Fusco M: Mast
cells in chronic inflammation, pelvic pain and depression in women.
Gynecol Endocrinol. 30:472–477. 2014.
|
|
82
|
Rana N, Braun DP, House R, Gebel H, Rotman
C and Dmowski WP: Basal and stimulated secretion of cytokines by
peritoneal macrophages in women with endometriosis. Fertil Steril.
65:925–930. 1996.
|
|
83
|
Bedaiwy MA and Falcone T: Peritoneal fluid
environment in endometriosis. Clinicopathological implications.
Minerva Ginecol. 55:333–345. 2003.
|
|
84
|
Nikolov NP and Illei GG: Pathogenesis of
Sjogren's syndrome. Curr Opin Rheumatol. 21:465–470. 2009.
|
|
85
|
Voulgarelis M and Tzioufas AG:
Pathogenetic mechanisms in the initiation and perpetuation of
Sjögren's syndrome. Nat Rev Rheumatol. 6:529–537. 2010.
|
|
86
|
Manukyan G, Ghazaryan K, Ktsoyan Z,
Khachatryan Z, Kelly D, Tatyan M, Agababova M and Aminov R:
Comparative analysis of cytokine profiles in autoinflammatory and
autoimmune conditions. Cytokine. 50:146–151. 2010.
|
|
87
|
Fox PC and Speight PM: Current concepts of
autoimmune exocrinopathy: Immunologic mechanisms in the salivary
pathology of Sjögren's syndrome. Crit Rev Oral Biol Med. 7:144–158.
1996.
|
|
88
|
Merrill JE, Kono DH, Clayton J, Ando DG,
Hinton DR and Hofman FM: Inflammatory leukocytes and cytokines in
the peptide-induced disease of experimental allergic
encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci USA.
89:574–578. 1992.
|
|
89
|
Ohyama Y, Nakamura S, Matsuzaki G,
Shinohara M, Hiroki A, Fujimura T, Yamada A, Itoh K and Nomoto K:
Cytokine messenger RNA expression in the labial salivary glands of
patients with Sjögren's syndrome. Arthritis Rheum. 39:1376–1384.
1996.
|
|
90
|
Sjögren E, Leanderson P, Kristenson M and
Ernerudh J: Interleukin-6 levels in relation to psychosocial
factors: Studies on serum, saliva, and in vitro production by blood
mononuclear cells. Brain Behav Immun. 20:270–278. 2006.
|
|
91
|
Sakai A, Sugawara Y, Kuroishi T, Sasano T
and Sugawara S: Identification of IL-18 and Th17 cells in salivary
glands of patients with Sjögren's syndrome, and amplification of
IL-17-mediated secretion of inflammatory cytokines from salivary
gland cells by IL-18. J Immunol. 181:2898–2906. 2008.
|
|
92
|
Nguyen CQ, Hu MH, Li Y, Stewart C and Peck
AB: Salivary gland tissue expression of interleukin-23 and
interleukin-17 in Sjögren's syndrome: Findings in humans and mice.
Arthritis Rheum. 58:734–743. 2008.
|
|
93
|
Katsifis GE, Rekka S, Moutsopoulos NM,
Pillemer S and Wahl SM: Systemic and local interleukin-17 and
linked cytokines associated with Sjögren's syndrome
immunopathogenesis. Am J Pathol. 175:1167–1177. 2009.
|
|
94
|
Oxholm P, Daniels TE and Bendtzen K:
Cytokine expression in labial salivary glands from patients with
primary Sjögren's syndrome. Autoimmunity. 12:185–191. 1992.
|
|
95
|
Koski H, Janin A, Humphreys-Beher MG,
Sorsa T, Malmström M and Konttinen YT: Tumor necrosis factor-alpha
and receptors for it in labial salivary glands in Sjögren's
syndrome. Clin Exp Rheumatol. 19:131–137. 2001.
|
|
96
|
Mackay F and Tangye SG: The role of the
BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr
Opin Pharmacol. 4:347–354. 2004.
|
|
97
|
Carrillo-Ballesteros FJ, Palafox-Sánchez
CA, Franco-Topete RA, Muñoz-Valle JF, Orozco-Barocio G,
Martínez-Bonilla GE, Gómez-López CE, Marín-Rosales M,
López-Villalobos EF, Luquin S, et al: Expression of BAFF and BAFF
receptors in primary Sjögren's syndrome patients with ectopic
germinal center-like structures. Clin Exp Med. 20:615–626.
2020.
|
|
98
|
Mavragani CP: Mechanisms and new
strategies for primary Sjögren's syndrome. Annu Rev Med.
68:331–343. 2017.
|
|
99
|
Hagiwara E, Pando J, Ishigatsubo Y and
Klinman DM: Altered frequency of type 1 cytokine secreting cells in
the peripheral blood of patients with primary Sjögren's syndrome. J
Rheumatol. 25:89–93. 1998.
|
|
100
|
Garcíc-Carrasco M, Font J, Filella X,
Cervera R, Ramos-Casals M, Sisó A, Aymamí A, Ballesta AM and
Ingelmo M: Circulating levels of Th1/Th2 cytokines in patients with
primary Sjögren's syndrome: Correlation with clinical and
immunological features. Clin Exp Rheumatol. 19:411–415. 2001.
|
|
101
|
McLaren J: Vascular endothelial growth
factor and endometriotic angiogenesis. Hum Reprod Update. 6:45–55.
2000.
|
|
102
|
Malhotra N, Karmakar D, Tripathi V, Luthra
K and Kumar S: Correlation of angiogenic cytokines-leptin and IL-8
in stage, type and presentation of endometriosis. Gynecol
Endocrinol. 28:224–227. 2012.
|
|
103
|
Maas JW, Le Noble FA, Dunselman GA, De
Goeij AF, Struyker Boudier HA and Evers Jl: The chick embryo
chorioallantoic membrane as a model to investigate the angiogenic
properties of human endometrium. Gynecol Obstet Invest. 48:108–112.
1999.
|
|
104
|
Griffioen AW and Molema G: Angiogenesis:
Potentials for pharmacologic intervention in the treatment of
cancer, cardiovascular diseases, and chronic inflammation.
Pharmacol Rev. 52:237–268. 2000.
|
|
105
|
Barleon B, Reusch P, Totzke F, Herzog C,
Keck C, Martiny-Baron G and Marmé D: Soluble VEGFR-1 secreted by
endothelial cells and monocytes is present in human serum and
plasma from healthy donors. Angiogenesis. 4:143–154. 2001.
|
|
106
|
Carmeliet P, Moons L, Luttun A, Vincenti
V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, et al:
Synergism between vascular endothelial growth factor and placental
growth factor contributes to angiogenesis and plasma extravasation
in pathological conditions. Nat Med. 7:575–583. 2001.
|
|
107
|
Donnez J, Smoes P, Gillerot S,
Casanas-Roux F and Nisolle M: Vascular endothelial growth factor
(VEGF) in endometriosis. Hum Reprod. 13:1686–1690. 1998.
|
|
108
|
Melder RJ, Koenig GC, Witwer BP,
Safabakhsh N, Munn LL and Jain R: During angiogenesis, vascular
endothelial growth factor and basic fibroblast growth factor
regulate natural killer cell adhesion to tumor endothelium. Nat
Med. 2:992–997. 1996.
|
|
109
|
Kirchhoff D, Kaulfuss S, Fuhrmann U,
Maurer M and Zollner TM: Mast cells in endometriosis: Guilty or
innocent bystanders? Expert Opin Ther Targets. 16:237–241.
2012.
|
|
110
|
Sisto M, Ribatti D and Lisi S: Molecular
mechanisms linking inflammation to autoimmunity in Sjögren's
syndrome: Identification of new targets. Int J Mol Sci.
23:132292022.
|
|
111
|
Ribatti D and Crivellato E: 'Sprouting
angiogenesis', a reappraisal. Dev Biol. 372:157–165. 2012.
|
|
112
|
Rundhaug JE: Matrix metalloproteinases and
angiogenesis. J Cell Mol Med. 9:267–285. 2005.
|
|
113
|
Swendeman S, Mendelson K, Weskamp G,
Horiuchi K, Deutsch U, Scherle P, Hooper A, Rafii S and Blobel CP:
VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk
between VEGFR2 and ERK signaling. Circ Res. 103:916–918. 2008.
|
|
114
|
Sisto M, Lisi S, Lofrumento DD, D'Amore M,
Frassanito MA and Ribatti D: Sjögren's syndrome pathological
neovascularization is regulated by VEGF-A-stimulated TACE-dependent
crosstalk between VEGFR2 and NF-κB. Genes Immun. 13:411–420.
2012.
|
|
115
|
Gerli R, Vaudo G, Bocci EB, Schillaci G,
Alunno A, Luccioli F, Hijazi R, Mannarino E and Shoenfeld Y:
Functional impairment of the arterial wall in primary Sjögren's
syndrome: Combined action of immunologic and inflammatory factors.
Arthritis Care Res (Hoboken). 62:712–718. 2010.
|
|
116
|
Sisto M, Lisi S, Lofrumento DD, D'Amore M
and Ribatti D: Neuropilin-1 is upregulated in Sjögren's syndrome
and contributes to pathological neovascularization. Histochem Cell
Biol. 137:669–677. 2012.
|
|
117
|
Alunno A, Ibba-Manneschi L, Bistoni O,
Cipriani S, Topini F, Gerli R and Manetti M: Angiogenic T cells in
primary Sjögren's syndrome: A double-edged sword? Clin Exp
Rheumatol. 37(Suppl 118): S36–S41. 2019.
|
|
118
|
Bianco B, André GM, Vilarino FL, Peluso C,
Mafra FA, Christofolini DM and Barbosa CP: The possible role of
genetic variants in autoimmune-related genes in the development of
endometriosis. Hum Immunol. 73:306–315. 2012.
|
|
119
|
Nordmark G, Kristjansdottir G, Theander E,
Eriksson P, Brun JG, Wang C, Padyukov L, Truedsson L, Alm G,
Eloranta ML, et al: Additive effects of the major risk alleles of
IRF5 and STAT4 in primary Sjögren's syndrome. Genes Immun.
10:68–76. 2009.
|
|
120
|
Bianco B, Fernandes RFM, Trevisan CM,
Christofolini DM, Sanz-Lomana CM, de Bernabe JV and Barbosa CP:
Influence of STAT4 gene polymorphisms in the pathogenesis of
endometriosis. Ann Hum Genet. 83:249–255. 2019.
|
|
121
|
Zamani MR, Salmaninejad A, Akbari Asbagh
F, Masoud A and Rezaei N: STAT4 single nucleotide gene
polymorphisms and susceptibility to endometriosis-related
infertility. Eur J Obstet Gynecol Reprod Biol. 203:20–24. 2016.
|
|
122
|
Gestermann N, Mekinian A, Comets E,
Loiseau P, Puechal X, Hachulla E, Gottenberg JE, Mariette X and
Miceli-Richard C: STAT4 is a confirmed genetic risk factor for
Sjögren's syndrome and could be involved in type 1 interferon
pathway signaling. Genes Immun. 11:432–438. 2010.
|
|
123
|
Gomes FMCS, Bianco B, Teles JS,
Christofolini DM, de Souza AMB, Guedes AD and Barbosa CP: PTPN22
C1858T polymorphism in women with endometriosis. Am J Reprod
Immunol. 63:227–232. 2010.
|
|
124
|
Veena KV, Manolla ML, Deenadayal M,
Shivaji S and Bhanoori M: The rs2304256, a non-synonymous
polymorphism in tyrosine kinase 2 gene is associated with the risk
of endometriosis. Austin J Obstet Gynecol. 10:12162023.
|
|
125
|
Mier-Cabrera J, Cruz-Orozco O, de la
Jara-Díaz J, Galicia-Castillo O, Buenrostro-Jáuregui M,
Parra-Carriedo A and Hernández-Guerrero C: Polymorphisms of
TNF-alpha (-308), IL-1beta (+3954) and IL1-Ra (VNTR) are associated
to severe stage of endometriosis in Mexican women: A case control
study. BMC Womens Health. 22:3562022.
|
|
126
|
Qin B, Wang J, Liang Y, Yang Z and Zhong
R: The association between TNF-α, IL-10 gene polymorphisms and
primary Sjögren's syndrome: A meta-analysis and systemic review.
PLoS One. 8:e634012013.
|
|
127
|
Vodolazkaia A, Yesilyurt BT, Kyama CM,
Bokor A, Schols D, Huskens D, Meuleman C, Peeraer K, Tomassetti C,
Bossuyt X, et al: Vascular endothelial growth factor pathway in
endometriosis: Genetic variants and plasma biomarkers. Fertil
Steril. 105:988–996. 2016.
|
|
128
|
Adewuyi EO, Mehta D; International
Endogene Consortium (IEC); 23andMe Research Team; Nyholt DR:
Genetic overlap analysis of endometriosis and asthma identifies
shared loci implicating sex hormones and thyroid signalling
pathways. Hum Reprod. 37:366–383. 2022.
|
|
129
|
Ishii K, Takakuwa K, Kashima K, Tamura M
and Tanaka K: Associations between patients with endometriosis and
HLA class II; the analysis of HLA-DQB1 and HLA-DPB1 genotypes. Hum
Reprod. 18:985–989. 2003.
|
|
130
|
Cruz-Tapias P, Rojas-Villarraga A,
Maier-Moore S and Anaya JM: HLA and Sjögren's syndrome
susceptibility. A meta-analysis of worldwide studies. Autoimmun
Rev. 11:281–287. 2012.
|
|
131
|
Kitawaki J, Obayashi H, Kado N, Ishihara
H, Koshiba H, Maruya E, Saji H, Ohta M, Hasegawa G, Nakamura N, et
al: Association of HLA class I and class II alleles with
susceptibility to endometriosis. Hum Immunol. 63:1033–1038.
2002.
|
|
132
|
Frucht DM, Aringer M, Galon J, Danning C,
Brown M, Fan S, Centola M, Wu CY, Yamada N, El Gabalawy H and
O'Shea JJ: Stat4 is expressed in activated peripheral blood
monocytes, dendritic cells, and macrophages at sites of
Th1-mediated inflammation. J Immunol. 164:4659–4664. 2000.
|
|
133
|
Korman BD, Kastner DL, Gregersen PK and
Remmers EF: STAT4: Genetics, mechanisms, and implications for
autoimmunity. Curr Allergy Asthma Rep. 8:398–403. 2008.
|
|
134
|
Remmers EF, Plenge RM, Lee AT, Graham RR,
Hom G, Behrens TW, de Bakker PI, Le JM, Lee HS, Batliwalla F, et
al: STAT4 and the risk of rheumatoid arthritis and systemic lupus
erythematosus. N Engl J Med. 357:977–986. 2007.
|
|
135
|
Kariuki SN, Kirou KA, MacDermott EJ,
Barillas-Arias L, Crow MK and Niewold TB: Cutting edge: Autoimmune
disease risk variant of STAT4 confers increased sensitivity to
IFN-alpha in lupus patients in vivo. J Immunol. 182:34–38.
2009.
|
|
136
|
Kofteridis D, Krasoudaki E, Kavousanaki M,
Zervou MI, Panierakis C, Boumpas DT and Goulielmos GN: STAT4 is not
associated with type 2 diabetes in the genetically homogeneous
population of Crete. Genet Test Mol Biomarkers. 13:281–284.
2009.
|
|
137
|
Podgaec S, Dias Junior JA, Chapron C,
Oliveira RM, Baracat EC and Abrão MS: Th1 and Th2 ummune responses
related to pelvic endometriosis. Rev Assoc Med Bras (1992).
56:92–98. 2010.
|
|
138
|
Ryzhakov G, Eames HL and Udalova IA:
Activation and function of interferon regulatory factor 5. J
Interferon Cytokine Res. 35:71–78. 2015.
|
|
139
|
Taniguchi T, Ogasawara K, Takaoka A and
Tanaka N: IRF family of transcription factors as regulators of host
defense. Annu Rev Immunol. 19:623–655. 2001.
|
|
140
|
Chang Foreman HC, Van Scoy S, Cheng TF and
Reich NC: Activation of interferon regulatory factor 5 by site
specific phosphorylation. PLoS One. 7:e330982012.
|
|
141
|
Krausgruber T, Blazek K, Smallie T,
Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M and Udalova
IA: IRF5 promotes inflammatory macrophage polarization and TH1-TH17
responses. Nat Immunol. 12:231–238. 2011.
|
|
142
|
Bianco B, De Camargo CR, Christofolini DM
and Barbosa CP: Involvement of interferon regulatory factor 5
(IRF5) gene polymorphisms and haplotype in endometriosis-related
infertility. J Endometr Pelvic Pain Disord. 9:188–192. 2017.
|
|
143
|
Miceli-Richard C, Comets E, Loiseau P,
Puechal X, Hachulla E and Mariette X: Association of an IRF5 gene
functional polymorphism with Sjögren's syndrome. Arthritis Rheum.
56:3989–3994. 2007.
|
|
144
|
Niewold TB, Kelly JA, Kariuki SN, Franek
BS, Kumar AA, Kaufman KM, Thomas K, Walker D, Kamp S, Frost JM, et
al: IRF5 haplotypes demonstrate diverse serological associations
which predict serum interferon alpha activity and explain the
majority of the genetic association with systemic lupus
erythematosus. Ann Rheum Dis. 71:463–468. 2012.
|
|
145
|
Wang K, Li M and Hakonarson H: Analysing
biological pathways in genome-wide association studies. Nat Rev
Genet. 11:843–854. 2010.
|
|
146
|
Burbelo PD, Ambatipudi K and Alevizos I:
Genome-wide association studies in Sjögren's syndrome: What do the
genes tell us about disease pathogenesis? Autoimmun Rev.
13:756–761. 2014.
|
|
147
|
Zervou MI, Dorschner JM, Ghodke-Puranik Y,
Boumpas DT, Niewold TB and Goulielmos GN: Association of IRF5
polymorphisms with increased risk for systemic lupus erythematosus
in population of Crete, a southern-eastern European Greek island.
Gene. 610:9–14. 2017.
|
|
148
|
Sankararaman S, Mallick S, Dannemann M,
Prüfer K, Kelso J, Pääbo S, Patterson N and Reich D: The genomic
landscape of Neanderthal ancestry in present-day humans. Nature.
507:354–357. 2014.
|
|
149
|
Wu J, Katrekar A, Honigberg LA, Smith AM,
Conn MT, Tang J, Jeffery D, Mortara K, Sampang J, Williams SR, et
al: Identification of substrates of human protein-tyrosine
phosphatase PTPN22. J Biol Chem. 281:11002–11010. 2006.
|
|
150
|
Cohen S, Dadi H, Shaoul E, Sharfe N and
Roifman CM: Cloning and characterization of a lymphoid-specific,
inducible human protein tyrosine phosphatase, Lyp. Blood.
93:2013–2024. 1999.
|
|
151
|
Gomez LM, Anaya JM, Gonzalez CI,
Pineda-Tamayo R, Otero W, Arango A and Martín J: PTPN22 C1858T
polymorphism in Colombian patients with autoimmune diseases. Genes
Immun. 6:628–631. 2005.
|
|
152
|
Cloutier JF and Veillette A: Cooperative
inhibition of T-cell antigen receptor signaling by a complex
between a kinase and a phosphatase. J Exp Med. 189:111–121.
1999.
|
|
153
|
Lee YH, Rho YH, Choi SJ, Ji JD, Song GG,
Nath SK and Harley JB: The PTPN22 C1858T functional polymorphism
and autoimmune diseases-a meta-analysis. Rheumatology (Oxford).
46:49–56. 2007.
|
|
154
|
Bottini N, Musumeci L, Alonso A, Rahmouni
S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P,
Pellecchia M, et al: A functional variant of lymphoid tyrosine
phosphatase is associated with type I diabetes. Nat Genet.
36:337–338. 2004.
|
|
155
|
Dmowski WP, Gebel HM and Braun DP: The
role of cell-mediated immunity in pathogenesis of endometriosis.
Acta Obstet Gynecol Scand Suppl. 159:7–14. 1994.
|
|
156
|
Eyre S, Bowes J, Diogo D, Lee A, Barton A,
Martin P, Zhernakova A, Stahl E, Viatte S, McAllister K, et al:
High-density genetic mapping identifies new susceptibility loci for
rheumatoid arthritis. Nat Genet. 44:1336–1340. 2012.
|
|
157
|
Diogo D, Bastarache L, Liao KP, Graham RR,
Fulton RS, Greenberg JD, Eyre S, Bowes J, Cui J, Lee A, et al: TYK2
protein-coding variants protect against rheumatoid arthritis and
autoimmunity, with no evidence of major pleiotropic effects on
non-autoimmune complex traits. PLoS One. 10:e01222712015.
|
|
158
|
Kyogoku C, Morinobu A, Nishimura K,
Sugiyama D, Hashimoto H, Tokano Y, Mimori T, Terao C, Matsuda F,
Kuno T and Kumagai S: Lack of association between tyrosine kinase 2
(TYK2) gene polymorphisms and susceptibility to SLE in a Japanese
population. Mod Rheumatol. 19:401–406. 2009.
|
|
159
|
Tokumasa N, Suto A, Kagami S, Furuta S,
Hirose K, Watanabe N, Saito Y, Shimoda K, Iwamoto I and Nakajima H:
Expression of Tyk2 in dendritic cells is required for IL-12, IL-23,
and IFN-gamma production and the induction of Th1 cell
differentiation. Blood. 110:553–560. 2007.
|
|
160
|
Li Z, Rotival M, Patin E, Michel F and
Pellegrini S: Two common disease-associated TYK2 variants impact
exon splicing and TYK2 dosage. PLoS One. 15:e02252892020.
|
|
161
|
Chegini N, Roberts M and Ripps B:
Differential expression of interleukins (IL)-13 and IL-15 in
ectopic and eutopic endometrium of women with endometriosis and
normal fertile women. Am J Reprod Immunol. 49:75–83. 2003.
|
|
162
|
Wang F, Wang H, Jin D and Zhang Y: Serum
miR-17, IL-4, and IL-6 levels for diagnosis of endometriosis.
Medicine (Baltimore). 97:e108532018.
|
|
163
|
Kelly-Welch AE, Hanson EM, Boothby MR and
Keegan AD: Interleukin-4 and interleukin-13 signaling connections
maps. Science. 300:1527–1528. 2003.
|
|
164
|
Roberts M, Luo X and Chegini N:
Differential regulation of interleukins IL-13 and IL-15 by ovarian
steroids, TNF-alpha and TGF-beta in human endometrial epithelial
and stromal cells. Mol Hum Reprod. 11:751–760. 2005.
|
|
165
|
Karjalainen A, Shoebridge S, Krunic M,
Simonović N, Tebb G, Macho-Maschler S, Strobl B and Müller M: TYK2
in tumor immunosurveillance. Cancers (Basel). 12:1502020.
|
|
166
|
Goronzy JJ, Zettl A and Weyand CM: T cell
receptor repertoire in rheumatoid arthritis. Int Rev Immunol.
17:339–363. 1998.
|
|
167
|
Morling N, Andersen V, Fugger L, Georgsen
J, Halberg P, Oxholm P, Odum N and Svejgaard A: Immunogenetics of
rheumatoid arthritis and primary Sjögren's syndrome: DNA
polymorphism of HLA class II genes. Dis Markers. 9:289–296.
1991.
|
|
168
|
Marsh SG and Bodmer JG: HLA class II
nucleotide sequences, 1991. Hum Immunol. 31:207–227. 1991.
|
|
169
|
Cowan EP, Pierce ML, McFarland HF and
McFarlin DE: HLA-DR and -DQ allelic sequences in multiple sclerosis
patients are identical to those found in the general population.
Hum Immunol. 32:203–210. 1991.
|
|
170
|
Reveille JD, Fischbach M, Mcnearney T,
Friedman AW, Aguilar MB, Lisse J, Fritzler MJ, Ahn C and Arnett FC;
GENISOS Study Group: Systemic sclerosis in 3 US ethnic groups: A
comparison of clinical, sociodemographic, serologic, and
immunogenetic determinants. Semin Arthritis Rheum. 30:332–346.
2001.
|
|
171
|
Hodak E, Lapidoth M, Kohn K, David D,
Brautbar B, Kfir K, Narinski N, Safirman S, Maron M and Klein K:
Mycosis fungoides: HLA class II associations among Ashkenazi and
non-Ashkenazi Jewish patients. Br J Dermatol. 145:974–980.
2001.
|
|
172
|
Semino C, Semino A, Pietra G, Mingari MC,
Barocci S, Venturini PL, Ragni N and Melioli G: Role of major
histocompatibility complex class I expression and natural
killer-like T cells in the genetic control of endometriosis. Fertil
Steril. 64:909–916. 1995.
|
|
173
|
Fox RI, Kang HI, Ando D, Abrams J and Pisa
E: Cytokine mRNA expression in salivary gland biopsies of Sjögren's
syndrome. J Immunol. 152:5532–5539. 1994.
|
|
174
|
Abutorabi R, Baradaran A, Sadat Mostafavi
F, Zarrin Y and Mardanian F: Evaluation of tumor necrosis factor
alpha polymorphism frequencies in endometriosis. Int J Fertil
Steril. 9:329–337. 2015.
|
|
175
|
Harada T, Iwabe T and Terakawa N: Role of
cytokines in endometriosis. Fertil Steril. 76:1–10. 2001.
|
|
176
|
Brennan FM and Feldmann M: Cytokines in
autoimmunity. Curr Opin Immunol. 8:872–877. 1996.
|
|
177
|
Gupta V, Gupta A, Jafar T, Gupta V,
Agrawal S, Srivastava N, Kumar S, Singh AK, Natu SM, Agarwal CG and
Agarwal GG: Association of TNF-α promoter gene G-308A polymorphism
with metabolic syndrome, insulin resistance, serum TNF-α and leptin
levels in Indian adult women. Cytokine. 57:32–36. 2012.
|
|
178
|
Bischoff F and Simpson JL: Genetic basis
of endometriosis. Ann N Y Acad Sci. 1034:284–299. 2004.
|
|
179
|
Cramer DW and Missmer SA: The epidemiology
of endometriosis. Ann NY Acad Sci. 955:11–22. 34–36. 396–406.
2002.
|
|
180
|
Kyama CM, Overbergh L, Debrock S, Valckx
D, Vander Perre S, Meuleman C, Mihalyi A, Mwenda JM, Mathieu C and
D'Hooghe TM: Increased peritoneal and endometrial gene expression
of biologically relevant cytokines and growth factors during the
menstrual phase in women with endometriosis. Fertil Steril.
85:1667–1675. 2006.
|
|
181
|
Bertorello R, Cordone MP, Contini P, Rossi
P, Indiveri F, Puppo F and Cordon G: Increased levels of
interleukin-10 in saliva of Sjögren's syndrome patients.
Correlation with disease activity. Clin Exp Med. 4:148–151.
2004.
|
|
182
|
Jaakkola P, Mole DR, Tian YM, Wilson MI,
Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji
M, Schofield CJ, et al: Targeting of HIF-alpha to the von
Hippel-Lindau ubiquitylation complex by O2-regulated prolyl
hydroxylation. Science. 292:468–472. 2001.
|
|
183
|
Palazon A, Goldrath AW, Nizet V and Ohnson
RS: HIF transcription factors, inflammation, and immunity.
Immunity. 41:518–528. 2014.
|
|
184
|
Shan B, Gerez J, Haedo M, Fuertes M,
Theodoropoulou M, Buchfelder M, Losa M, Stalla GK, Arzt E and
Renner U: RSUME is implicated in HIF-1-induced VEGF-A production in
pituitary tumour cells. Endocr Relat Cancer. 19:13–27. 2012.
|
|
185
|
Hua S and Dias TH: Hypoxia-inducible
factor (HIF) as a target for novel therapies in rheumatoid
arthritis. Front Pharmacol. 7:1842016.
|
|
186
|
Yang ZC and Liu Y: Hypoxia-inducible
factor-1α and autoimmune lupus, arthritis. Inflammation.
39:1268–1273. 2016.
|
|
187
|
Clifford SC, Astuti D, Hooper L, Maxwell
PH, Ratcliffe PJ and Maher ER: The pVHL-associated SCF ubiquitin
ligase complex: Molecular genetic analysis of elongin B and C, Rbx1
and HIF-1alpha in renal cell carcinoma. Oncogene. 20:5067–5074.
2001.
|
|
188
|
Dang EV, Barbi J, Yang HY, Jinasena D, Yu
H, Zheng Y, Bordman Z, Fu J, Kim Y, Yen HR, et al: Control of
T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell.
146:772–784. 2011.
|
|
189
|
Hu F, Liu H, Xu L, Li Y, Liu X, Shi L, Su
Y, Qiu X, Zhang X, Yang Y, et al: Hypoxia-inducible factor-1α
perpetuates synovial fibroblast interactions with T cells and B
cells in rheumatoid arthritis. Eur J Immunol. 46:742–751. 2016.
|
|
190
|
Nezos A, Gravani F, Tassidou A,
Kapsogeorgou EK, Voulgarelis M, Koutsilieris M, Crow MK and
Mavragani C: Type I and II interferon signatures in Sjogren's
syndrome pathogenesis: Contributions in distinct clinical
phenotypes and Sjogren's related lymphomagenesis. J Autoimmun.
63:47–58. 2015.
|
|
191
|
Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu
M, Ukon K, Kumazaki T, Oue N, Yasui W, Imai K, Nakachi K, et al:
Hypoxia-inducible factor-1alpha polymorphisms associated with
enhanced transactivation capacity, implying clinical significance.
Carcinogenesis. 24:1779–1783. 2003.
|
|
192
|
Collec E, Colin Y, Carbonnet F, Hattab C,
Bertrand O, Cartron JP and Kim CL: Structure and expression of the
mouse homologue of the XK gene. Immunogenetics. 50:16–21. 1999.
|
|
193
|
Joo YB, Lim J, Tsao BP, Nath SK, Kim K and
Bae SC: Genetic variants in systemic lupus erythematosus
susceptibility loci, XKR6 and GLT1D1 are associated with
childhood-onset SLE in a Korean cohort. Sci Rep. 8:99622018.
|
|
194
|
Cordero RY, Cordero JB, Stiemke AB, Datta
LW, Buyske S, Kugathasan S, McGovern DPB, Brant SR and Simpson CL:
Trans-ancestry, Bayesian meta-analysis discovers 20 novel risk loci
for inflammatory bowel disease in an African American, East Asian
and European cohort. Hum Mol Genet. 32:873–882. 2023.
|
|
195
|
Kottyan LC, Davis BP, Sherrill JD, Liu K,
Rochman M, Kaufman K, Weirauch MT, Vaughn S, Lazaro S, Rupert AM,
et al: Genome-wide association analysis of eosinophilic esophagitis
provides insight into the tissue specificity of this allergic
disease. Nat Genet. 46:895–900. 2014.
|
|
196
|
Saj A and Lai EC: Control of microRNA
biogenesis and transcription by cell signaling pathways. Curr Opin
Genet Dev. 21:504–510. 2011.
|
|
197
|
Marí-Alexandre J, Sánchez-Izquierdo D,
Gilabert-Estellés J, Barceló-Molina M, Braza-Boïls A and Sandoval
J: miRNAs regulation and its role as biomarkers in endometriosis.
Int J Mol Sci. 17:932016.
|
|
198
|
Dai R and Ahmed SA: MicroRNA, a new
paradigm for understanding immunoregulation, inflammation, and
autoimmune diseases. Transl Res. 157:163–179. 2011.
|
|
199
|
Garo LP and Murugaiyan G: Contribution of
microRNAs to autoimmune diseases. Cell Mol Life Sci. 73:2041–2051.
2016.
|
|
200
|
Qu Z, Li W and Fu B: MicroRNAs in
autoimmune diseases. Biomed Res Int. 2014:5278952014.
|
|
201
|
Yang Y, Peng L, Ma W, Yi F, Zhang Z, Chen
H, Guo Y, Wang L, Zhao LD, Zheng W, et al: Autoantigen-targeting
microRNAs in Sjögren's syndrome. Clin Rheumatol. 35:911–917.
2016.
|
|
202
|
Monnaka VU, Hernandes C, Heller D and
Podgaec S: Overview of miRNAs for the non-invasive diagnosis of
endometriosis: Evidence, challenges and strategies. A systematic
review. Einstein (Sao Paulo). 19:eRW57042021.In English,
Portuguese.
|
|
203
|
De Benedittis G, Ciccacci C, Latini A,
Novelli L, Novelli G and Borgiani P: Emerging role of microRNAs and
long non-coding RNAs in Sjögren's syndrome. Genes (Basel).
12:9032021.
|
|
204
|
Ghafouri-Fard S, Shoorei H and Taheri M:
Role of non-coding RNAs in the pathogenesis of endometriosis. Front
Oncol. 10:13702020.
|
|
205
|
Reale M, D'Angelo C, Costantini E, Laus M,
Moretti A and Croce A: MicroRNA in Sjögren's syndrome: Their
potential roles in pathogenesis and diagnosis. J Immunol Res.
2018:75101742018.
|
|
206
|
Suryawanshi S, Vlad AM, Lin HM,
Mantia-Smaldone G, Laskey R, Lee M, Lin Y, Donnellan N, Klein-Patel
M, Lee T, et al: Plasma microRNAs as novel biomarkers for
endometriosis and endometriosis-associated ovarian cancer. Clin
Cancer Res. 19:1213–1224. 2013.
|
|
207
|
Cha S, Mona M, Lee KE, Kim DH and Han K:
MicroRNAs in autoimmune Sjögren's syndrome. Genomics Inform.
16:e192018.
|
|
208
|
Abdel-Rasheed M, Nour Eldeen G, Mahmoud M,
ElHefnawi M, Abu-Shahba N, Reda M, Elsetohy K, Nabil M, Elnoury A,
Taha T and Azmy O: MicroRNA expression analysis in endometriotic
serum treated mesenchymal stem cells. EXCLI J. 16:852–867.
2017.
|
|
209
|
Wang Y, Zhang G, Zhang L, Zhao M and Huang
H: Decreased microRNA-181a and -16 expression levels in the labial
salivary glands of Sjögren syndrome patients. Exp Ther Med.
15:426–432. 2018.
|
|
210
|
Alevizos I and Illei GG: MicroRNAs in
Sjögren's syndrome as a prototypic autoimmune disease. Autoimmun
Rev. 9:618–621. 2010.
|
|
211
|
Cosar E, Mamillapalli R, Ersoy GS, Cho S,
Seifer B and Taylor HS: Serum microRNAs as diagnostic markers of
endometriosis: A comprehensive array-based analysis. Fertil Steril.
106:402–409. 2016.
|
|
212
|
Yan T, Shen J, Chen J, Zhao M, Guo H and
Wang Y: Differential expression of miR-17-92 cluster among varying
histological stages of minor salivary gland in patients with
primary Sjögren's syndrome. Clin Exp Rheumatol. 37(Suppl 118):
S49–S54. 2019.
|
|
213
|
Wang-Renault SF, Boudaoud S, Nocturne G,
Roche E, Sigrist N, Daviaud C, Bugge Tinggaard A, Renault V,
Deleuze JF, Mariette X and Tost J: Deregulation of microRNA
expression in purified T and B lymphocytes from patients with
primary Sjögren's syndrome. Ann Rheum Dis. 77:133–140. 2018.
|
|
214
|
Qi H, Liang G, Yu J, Wang X, Liang Y, He
X, Feng T and Zhang J: Genome-wide profiling of miRNA expression
patterns in tubal endometriosis. Reproduction. 157:525–534.
2019.
|
|
215
|
Chen X, Jiang Y and Pan D: miR-30c may
serve a role in endometriosis by targeting plasminogen activator
inhibitor-1. Exp Ther Med. 14:4846–4852. 2017.
|
|
216
|
Maged AM, Deeb WS, El Amir A, Zaki SS, El
Sawah H, Al Mohamady M, Metwally AA and Katta MA: Diagnostic
accuracy of serum miR-122 and miR-199a in women with endometriosis.
Int J Gynecol Obstetr. 141:14–19. 2018.
|
|
217
|
Yang P, Wu Z, Ma C, Pan N, Wang Y and Yan
L: Endometrial miR-543 is downregulated during the implantation
window in women with endometriosis-related infertility. Reprod Sci.
26:900–908. 2019.
|
|
218
|
Cortes-Troncoso J, Jang SI, Perez P,
Hidalgo J, Ikeuchi T, Greenwell-Wild T, Warner BM, Moutsopoulos NM
and Alevizos I: T cell exosome-derived miR-142-3p impairs glandular
cell function in Sjögren's syndrome. JCI Insight.
5:e1334972020.
|
|
219
|
Shi H, Zheng LY, Zhang P and Yu CQ:
miR-146a and miR-155 expression in PBMCs from patients with
Sjögren's syndrome. J Oral Pathol Med. 43:792–797. 2014.
|
|
220
|
Ibáñez-Cabellos JS, Pallardó FV,
García-Giménez JL and Seco-Cervera M: Oxidative stress and
epigenetics: miRNA involvement in rare autoimmune diseases.
Antioxidants (Basel). 12:8002023.
|
|
221
|
Nisenblat V, Sharkey DJ, Wang Z, Evans SF,
Healey M, Ohlsson Teague EMC, Print CG, Robertson SA and Hull ML:
Plasma miRNAs display limited potential as diagnostic tools for
endometriosis. J Clin Endocrinol Metab. 104:1999–2022. 2019.
|
|
222
|
Azmy OM and Elgarf WT: MiRNA-130a, a
potential endometriosis inducing factor. Med Res J. 11:40–47.
2012.
|
|
223
|
Williams AEG, Choi K, Chan AL, Lee YJ,
Reeves WH, Bubb MR, Stewart CM and Cha S: Sjögren's
syndrome-associated microRNAs in CD14(+) monocytes unveils targeted
TGFβ signaling. Arthritis Res Ther. 18:952016.
|
|
224
|
Le Dantec C, Varin MM, Brooks WH, Pers JO,
Youinou P and Renaudineau Y: Epigenetics and Sjögren's syndrome.
Curr Pharm Biotechnol. 13:2046–2053. 2012.
|
|
225
|
Peng L, Ma W, Yi F, Yang YJ, Lin W, Chen
H, Zhang X, Zhang LH, Zhang F and Du Q: MicroRNA profiling in
Chinese patients with primary Sjögren syndrome reveals elevated
miRNA-181a in peripheral blood mononuclear cells. J Rheumatol.
41:2208–2213. 2014.
|
|
226
|
Saare M, Rekker K, Laisk-Podar T, Sõritsa
D, Roost AM, Simm J, Velthut-Meikas A, Samuel K, Metsalu T, Karro
H, et al: High-throughput sequencing approach uncovers the miRNome
of peritoneal endometriotic lesions and adjacent healthy tissues.
PLoS One. 9:e1126302014.
|
|
227
|
Pateisky P, Pils D, Szabo L, Kuessel L,
Husslein H, Schmitz A, Wenzl R and Yotova I: hsa-miRNA-154-5p
expression in plasma of endometriosis patients is a potential
diagnostic marker for the disease. Reprod Biomed Online.
37:449–466. 2018.
|
|
228
|
Yang RQ, Teng H, Xu XH, Liu SY, Wang YH,
Guo FJ and Liu XJ: Microarray analysis of microRNA deregulation and
angiogenesis-related proteins in endometriosis. Genet Mol Res.
15:150278262016.
|
|
229
|
Jia SZ, Yang Y, Lang J, Sun P and Leng J:
Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women
with endometriosis. Hum Reprod. 28:322–330. 2013.
|
|
230
|
Taguchi A, Yanagisawa K, Tanaka M, Cao K,
Matsuyama Y, Goto H and Takahashi T: Identification of
hypoxia-inducible factor-1 alpha as a novel target for miR-17-92
microRNA cluster. Cancer Res. 68:5540–5545. 2008.
|
|
231
|
Lei Z, Li B, Yang Z, Fang H, Zhang GM,
Feng ZH and Huang B: Regulation of HIF-1alpha and VEGF by miR-20b
tunes tumor cells to adapt to the alteration of oxygen
concentration. PLoS One. 4:e76292009.
|
|
232
|
Gutierrez LS and Gutierrez J:
Thrombospondin 1 in metabolic diseases. Front Endocrinol
(Lausanne). 12:6385362021.
|
|
233
|
Mogilyansky E and Rigoutsos I: The
miR-17/92 cluster: A comprehensive update on its genomics,
genetics, functions and increasingly important and numerous roles
in health and disease. Cell Death Differ. 20:1603–1614. 2013.
|
|
234
|
Baulina NM, Kulakova OG and Favorova OO:
MicroRNAs: The role in autoimmune inflammation. Acta Naturae.
8:21–33. 2016.
|
|
235
|
Xu X, Li Z, Liu J, Yu S and Wei Z:
MicroRNA expression profiling in endometriosis-associated
infertility and its relationship with endometrial receptivity
evaluated by ultrasound. J Xray Sci Technol. 25:523–532. 2017.
|
|
236
|
Infante-Menéndez J, López-Pastor AR,
González-López P, Gómez-Hernández A and Escribano O: The Interplay
between oxidative stress and miRNAs in obesity-associated hepatic
and vascular complications. Antioxidants (Basel). 9:6072020.
|
|
237
|
Qi H, Zhang J, Shang Y, Yuan S and Meng C:
Argon inhibits reactive oxygen species oxidative stress via the
miR-21-mediated PDCD4/PTEN pathway to prevent myocardial
ischemia/reperfusion injury. Bioengineered. 12:5529–5539. 2021.
|
|
238
|
Zhang B, Xu ZW, Wang KH, Lu TC and Du Y:
Complex regulatory network of microRNAs, transcription factors,
gene alterations in adrenocortical cancer. Asian Pacific J Cancer
Prev. 14:2265–2268. 2013.
|
|
239
|
Alsaleh G, François A, Philippe L, Gong
YZ, Bahram S, Cetin S, Pfeffer S, Gottenberg JE, Wachsmann D,
Georgei P and Sibilia J: MiR-30a-3p negatively regulates BAFF
synthesis in systemic sclerosis and rheumatoid arthritis
fibroblasts. PLoS One. 9:e1112662014.
|
|
240
|
Wang WT, Zhao YN, Han BW, Hong SJ and Chen
YQ: Circulating microRNAs identified in a genome-wide serum
microRNA expression analysis as noninvasive biomarkers for
endometriosis. J Clin Endocrinol Metab. 98:281–289. 2013.
|
|
241
|
Nahid MA, Pauley KM, Satoh M and Chan EK:
miR-146a is critical for endotox-ininduced tolerance: Implication
in innate immunity. J Biol Chem. 284:34590–34599. 2009.
|
|
242
|
Nahid MA, Satoh M and Chan EK: Mechanistic
role of microRNA-146a in endotoxin-induced differential
cross-regulation of TLR signaling. J Immunol. 186:1723–1734.
2010.
|
|
243
|
Lu LF, Boldin MP, Chaudhry A, Lin LL,
Taganov KD, Hanada T, Yoshimura A, Baltimore D and Rudensky AY:
Function of miR-146a in controlling Treg cell-mediated regulation
of Th1 responses. Cell. 142:914–929. 2010.
|
|
244
|
Curtale G, Citarella F, Carissimi C,
Goldoni M, Carucci N, Fulci V, Franceschini D, Meloni F, Barnaba V
and Macino G: An emerging player in the adaptive immune response:
microRNA-146a is a modulator of IL-2 expression and
activation-induced cell death in T lymphocytes. Blood. 115:265–273.
2010.
|
|
245
|
Tsitsiou E and Lindsay MA: microRNAs and
the immune response. Curr Opin Pharmacol. 9:514–520. 2009.
|
|
246
|
Zilahi E, Tarr T, Papp G, Griger Z, Sipka
S and Zeher M: Increased microRNA-146a/b, TRAF6 gene and decreased
IRAK1 gene expressions in the peripheral mononuclear cells of
patients with Sjögren's syndrome. Immunol Lett. 141:165–168.
2012.
|
|
247
|
Wang X, Xin S, Wang Y, Ju D, Wu Q, Qiu Y,
Niu X, Liu W, Li J and Ji P: MicroRNA-146a-5p enhances T helper 17
cell differentiation via decreasing a disintegrin and
metalloprotease 17 level in primary sjögren's syndrome.
Bioengineered. 2:310–324. 2021.
|
|
248
|
Gottfried E, Kreutz M and Mackensen A:
Tumor metabolism as modulator of immune response and tumor
progression. Semin Cancer Biol. 22:335–341. 2012.
|
|
249
|
Appel S, Le Hellard S, Bruland O, Brun JG,
Omdal R, Kristjansdottir G, Theander E, Nordmark G, Kvarnström M,
Eriksson P, et al: Potential association of muscarinic receptor 3
gene variants with primary Sjogren's syndrome. Ann Rheum Dis.
70:1327–1329. 2011.
|
|
250
|
Whisnant AW, Bogerd HP, Flores O, Ho P,
Powers JG, Sharova N, Stevenson M, Chen CH and Cullen BR: In-depth
analysis of the interaction of HIV-1 with cellular microRNA
biogenesis and effector mechanisms. mBio. 4:e0001932013.
|
|
251
|
Eggers JC, Martino V, Reinbold R, Schäfer
SD, Kiesel L, Starzinski-Powitz A, Schüring AN, Kemper B, Greve B
and Götte M: microRNA miR-200b affects proliferation, invasiveness
and stemness of endometriotic cells by targeting ZEB1, ZEB2 and
KLF4. Reprod Biomed Online. 32:434–445. 2016.
|
|
252
|
Matsuzaki S and Darcha C: Epithelial to
mesenchymal transition-like and mesenchymal to epithelial
transition-like processes might be involved in the pathogenesis of
pelvic endometriosis. Hum Reprod. 27:712–721. 2012.
|
|
253
|
Proestling K, Birner P, Gamperl S, Nirtl
N, Marton E, Yerlikaya G, Wenzl R, Streubel B and Husslein H:
Enhanced epithelial to mesenchymal transition (EMT) and upregulated
MYC in ectopic lesions contribute independently to endometriosis.
Reprod Biol Endocrinol. 13:752015.
|
|
254
|
Kapsogeorgou EK, Gourzi VC, Manoussakis
MN, Moutsopoulos HM and Tzioufas AG: Cellular microRNAs (miRNAs)
and Sjögren's syndrome: Candidate regulators of autoimmune response
and autoantigen expression. J Autoimmun. 37:129–135. 2011.
|
|
255
|
Jones Buie JN, Goodwin AJ, Cook JA,
Halushka PV and Fan H: The role of miRNAs in cardiovascular disease
risk factors. Atherosclerosis. 254:271–281. 2016.
|
|
256
|
Zeng Y, Zhang X, Kang K, Chen J, Wu Z,
Huang J, Lu W, Chen Y, Zhang J, Wang Z, et al: MicroRNA-223
attenuates hypoxia-induced vascular remodeling by targeting
RhoB/MLC2 in pulmonary arterial smooth muscle cells. Sci Rep.
6:249002016.
|
|
257
|
Fulci V, Scappucci G, Sebastiani GD,
Giannitti C, Franceschini D, Meloni F, Colombo T, Citarella F,
Barnaba V, Minisola G, et al: miR-223 is overexpressed in
T-lymphocytes of patients affected by rheumatoid arthritis. Hum
Immunol. 71:206–211. 2010.
|
|
258
|
Pan Q, Ma J and Guo K: miR-223 enhances
the neuroprotection of estradiol against oxidative stress injury by
inhibiting the FOXO3/TXNIP axis. Neurochem Res. 47:1865–1877.
2022.
|
|
259
|
Seli E and Arici A: Endometriosis:
Interaction of immune and endocrine systems. Semin Reprod Med.
21:135–144. 2003.
|
|
260
|
Badawy SZ, Cuenca V, Stitzel A and Tice D:
Immune rosettes of T and B lymphocytes in infertile women with
endometriosis. J Reprod Med. 32:194–197. 1987.
|
|
261
|
Nothnick WB: Treating endometriosis as an
autoimmune disease. Fertil Steril. 76:223–231. 2001.
|
|
262
|
Ma K: Endometriosis increases the risk for
Sjögren syndrome: A nationwide prospective cohort study. Oral Surg
Oral Med Oral Pathol Oral Radiol. 129:e192–e193. 2020.
|
|
263
|
Papageorgiou L, Andreou A, Zervou M,
Vlachakis D, Goulielmos GN and Eliopoulos E: A global population
genomic analysis shows novel insights into the genetic
characteristics of endometriosis. World Acad Sci J. 5:122023.
|
|
264
|
Shomron N and Levy C: MicroRNA-biogenesis
and pre-mRNA splicing crosstalk. J Biomed Biotechnol.
2009:5946782009.
|
|
265
|
Gregory RI, Yan KP, Amuthan G, Chendrimada
T, Doratotaj B, Cooch N and Shiekhattar R: The Microprocessor
complex mediates the genesis of microRNAs. Nature. 432:235–240.
2004.
|
|
266
|
Bendifallah S, Suisse S, Puchar A, Delbos
L, Poilblanc M, Descamps P, Golfier F, Jornea L, Bouteiller D,
Touboul C, et al: Salivary MicroRNA signature for diagnosis of
endometriosis. J Clin Med. 11:6122022.
|
|
267
|
Sutton S, Clutterbuck A, Harris P, Gent T,
Freeman S, Foster N, Barrett-Jolley R and Mobasheri A: The
contribution of the synovium, synovial derived inflammatory
cytokines and neuropeptides to the pathogenesis of osteoarthritis.
Vet J. 179:10–24. 2009.
|
|
268
|
Gaffen SL, Jain R, Garg AV and Cua DJ: The
IL-23-IL-17 immune axis: From mechanisms to therapeutic testing.
Nat Rev Immunol. 14:585–600. 2014.
|
|
269
|
Barrera MJ, Aguilera S, Castro I, Matus S,
Carvajal P, Molina C, González S, Jara D, Hermoso M and González
MJ: Tofacitinib counteracts IL-6 overexpression induced by
deficient autophagy: Implications in Sjögren's syndrome.
Rheumatology (Oxford). 60:1951–1962. 2021.
|
|
270
|
Kim BG, Yoo JY, Kim TH, Shin JH,
Langenheim JF, Ferguson SD, Fazleabas AT, Young SL, Lessey BA and
Jeong JW: Aberrant activation of signal transducer and activator of
transcription-3 (STAT3) signaling in endometriosis. Hum Reprod.
30:1069–1078. 2015.
|
|
271
|
Kotlyar AM, Mamillapalli R, Flores VA and
Taylor HS: Tofacitinib alters STAT3 signaling and leads to
endometriosis lesion regression. Mol Hum Reprod.
27:gaab0162021.
|
|
272
|
Iwabe T, Harada T, Tsudo T, Nagano Y,
Yoshida S, Tanikawa M and Terakawa N: Tumor necrosis factor-alpha
promotes proliferation of endometriotic stromal cells by inducing
interleukin-8 gene and protein expression. J Clin Endocrinol Metab.
85:824–829. 2000.
|
|
273
|
Xue YH, You LT, Ting HF, Chen YW, Sheng
ZY, Xie YD, Wang YH, Chiou JY and Wei JC: Increased risk of
rheumatoid arthritis among patients with endometriosis: A
nationwide population-based cohort study. Rheumatology (Oxford).
60:3326–3333. 2021.
|
|
274
|
Mohler KM, Torrance DS, Smith CA, Goodwin
RG, Stremler KE, Fung VP, Madani H and Widmer MB: Soluble tumor
necrosis factor (TNF) receptors are effective therapeutic agents in
lethal endotoxemia and function simultaneously as both TNF carriers
and TNF antagonists. J Immunol. 151:1548–1561. 1993.
|
|
275
|
Braun DP, Ding J and Dmowski WP:
Peritoneal fluid-mediated enhancement of eutopic and ectopic
endometrial cell proliferation is dependent on tumor necrosis
factor-alpha in women with endometriosis. Fertil Steril.
78:727–732. 2002.
|
|
276
|
Zandbelt MM, de Wilde P, van Damme P,
Hoyng CB, van de Putte L and van den Hoogen F: Etanercept in the
treatment of patients with primary Sjögren's syndrome: a pilot
study. J Rheumatol. 31:96–101. 2004.
|
|
277
|
Sankar V, Brennan MT, Kok MR, Leakan RA,
Smith JA, Manny J, Baum BJ and Pillemer SR: Etanercept in Sjögren's
syndrome: A twelve-week randomized, double-blind,
placebo-controlled pilot clinical trial. Arthritis Rheum.
50:2240–2245. 2004.
|
|
278
|
Moutsopoulos NM, Katsifis GE, Angelov N,
Leakan RA, Sankar V, Pillemer S and Wahl SM: Lack of efficacy of
etanercept in Sjögren syndrome correlates with failed suppression
of tumour necrosis factor alpha and systemic immune activation. Ann
Rheum Dis. 67:1437–1443. 2008.
|
|
279
|
Mariette X, Ravaud P, Steinfeld S, Baron
G, Goetz J, Hachulla E, Combe B, Puéchal X, Pennec Y, Sauvezie B,
et al: Inefficacy of infliximab in primary Sjögren's syndrome:
Results of the randomized, controlled trial of remicade in primary
Sjögren's syndrome (TRIPSS). Arthritis Rheum. 50:1270–1276.
2004.
|
|
280
|
Falconer H, Mwenda JM, Chai DC, Wagner C,
Song XY, Mihalyi A, Simsa P, Kyama C, Cornillie FJ, Bergqvist A, et
al: Treatment with anti-TNF monoclonal antibody (c5N) reduces the
extent of induced endometriosis in the baboon. Hum Reprod.
21:1856–1862. 2006.
|
|
281
|
Bardi M, Cornolti S, Iliakis A, Scorpiniti
A and Vitali M: Endometriosis therapy: Not only hormones and
surgery-the importance of a holistic approach. Am J Biomed Sci Res.
18:0025102023.
|
